Back to Journals » Therapeutics and Clinical Risk Management » Volume 17

Reexamining Ophthalmic Drugs, Safety and Tolerability in Phase 1 Clinical Trials

Total article views   HTML views PDF downloads Totals
2,565 Dovepress* 2,354+ 86 2,440
PubMed Central* 211 56 267
Totals 2,565 142 2,707
*Since 21 October 2021

View citations on PubMed Central and Google Scholar